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EBA

:   epidermolysis bullosa acquisita

NH‐RDC

:   RDCs of backbone amides

RDC

:   residual dipolar couplings

SPR

:   surface plasmon resonance

Anchoring fibrils contain type VII collagen as major component and bind skin proteins belonging to the basal lamina and the underlying connective tissue. Anchoring fibrils are important in linking these skin layers together [1](#feb412807-bib-0001){ref-type="ref"}, [2](#feb412807-bib-0002){ref-type="ref"}. The central collagenous domain of type VII collagen has an N‐terminal cysteine knot [3](#feb412807-bib-0003){ref-type="ref"} and shows several interruptions (Fig. [1](#feb412807-fig-0001){ref-type="fig"}). The longest interruption has been termed a hinge region [4](#feb412807-bib-0004){ref-type="ref"} and is structurally disordered [5](#feb412807-bib-0005){ref-type="ref"}. The collagen triple helix is flanked by a large N‐terminal (NC1) and a small C‐terminal (NC2) noncollagenous domain [6](#feb412807-bib-0006){ref-type="ref"}. The NC1 domain consists of eleven subdomains and interacts with other extracellular proteins like laminin‐332, type I and IV collagen [7](#feb412807-bib-0007){ref-type="ref"}, [8](#feb412807-bib-0008){ref-type="ref"}, [9](#feb412807-bib-0009){ref-type="ref"}. The interaction with type I collagen is mediated by a subdomain termed vWFA2 that has homology to the von Willebrand factor A domain 3 [10](#feb412807-bib-0010){ref-type="ref"}, [11](#feb412807-bib-0011){ref-type="ref"}.

![Domain architecture of type VII collagen. Type VII collagen forms homotrimers that later assemble to anchoring fibrils. Type VII collagen has a central collagenous domain (blue) with an N‐terminal cysteine knot (yellow). N‐ and C‐terminal are two noncollagenous domains NC1 and NC2 (A). NC1 subdomains have homology to adhesion domains and mediate important interactions of type VII collagen. The vWFA2 subdomain is N‐terminal of the triple‐helical region of type VII collagen (B). The amino acid sequence of the investigated protein is given in Fig. [S1](#feb412807-sup-0001){ref-type="supplementary-material"}.](FEB4-10-580-g001){#feb412807-fig-0001}

The importance of type VII collagen and its interactions with other skin proteins is highlighted by the skin blistering disease epidermolysis bullosa (EB) existing as a hereditary and an acquired form. Hereditary EB is characterized by mutations within type VII collagen leading -- in most cases -- to premature termination of the peptide chain or disturbance of the triple helical structure [12](#feb412807-bib-0012){ref-type="ref"}. The acquired form, epidermolysis bullosa acquisita (EBA), is characterized by a loss of tolerance against type VII collagen and serves as a model system for autoimmune skin blistering diseases [1](#feb412807-bib-0001){ref-type="ref"}, [13](#feb412807-bib-0013){ref-type="ref"}, [14](#feb412807-bib-0014){ref-type="ref"}, [15](#feb412807-bib-0015){ref-type="ref"}. Several pathogenic epitopes on type VII collagen have been identified in EBA and mouse models have been established featuring certain aspects of the human disease [16](#feb412807-bib-0016){ref-type="ref"}. These mouse models are very well characterized in terms of genetic factors leading to skin blistering [17](#feb412807-bib-0017){ref-type="ref"}, and also, data on metabolic changes due to the disease have been published [18](#feb412807-bib-0018){ref-type="ref"}. Autoantibodies against the vWFA2 domain are pathogenic in an immunization induced mouse model, and approximately 30% of sera from EBA patients recognize the vWFA2 domain [19](#feb412807-bib-0019){ref-type="ref"}. Despite the importance of type VII collagen and the multitude of clinical data on type VII collagen related diseases, there is a basic knowledge gap on structural information. Here, we provide first high‐resolution structural and dynamical data for the vWFA2 domain by combining X‐ray crystallography and NMR spectroscopy. Since the structural data showed that the RGD motif is accessible on the protein surface, the interaction of vWFA2 with cellular receptors was investigated in cell adhesion assays. Binding to cells was still observable after mutating the RGD motif; therefore, additional amino acids were mutated based on the protein structure. This finally led to the identification of two interactions that have so far not been attributed to the vWFA2 domain: integrin binding via the RGD motif and binding to laminin‐332. It seems that the vWFA2 domain has additional important functions besides the well‐established collagen binding.

Materials and methods {#feb412807-sec-0002}
=====================

Expression and purification of wild‐type and mutant vWFA2 {#feb412807-sec-0003}
---------------------------------------------------------

Unlabelled and ^15^N‐labelled samples of the vWFA2 subdomain (amino acids 1048--1238) of murine type VII collagen have been expressed and purified as described previously [20](#feb412807-bib-0020){ref-type="ref"}. In brief, vWFA2 was expressed as fusion protein with an N‐terminal chitin binding tag and a self‐cleaving intein. After cell lysis, the cleared cell lysate was loaded onto a chitin column and self‐cleavage of the intein was induced by a temperature and pH change. After incubation overnight, vWFA2 was eluted. Fractions containing protein were pooled, and buffer was exchanged by ultrafiltration (Amicon Centrifugal filters, Merck Millipore, Carrigtwohill, Ireland; 10 kD MWCO). Mutants of vWFA2 for investigating cell adhesion have been obtained by site‐directed mutagenesis as described in Ref. [11](#feb412807-bib-0011){ref-type="ref"} and purified as wild‐type vWFA2. Initially, the RGD motif of vWFA2 was inversed (R1171D D1173R). Since this mutant (termed DGR mutant) was still positive in the cell attachment assay, additional mutations were introduced: D1209R, D1218R, D1229R, R1120Q K1121R, R1079E R1120Q K1121R, R1120Q K1121R R1225D, R1120Q K1121R D1218R. These amino acids have been selected according to the crystal structure, that is surface accessibility and charges (which are inverted in mutant proteins). Further mutations with an intact RGD motif that has been investigated are as follows: R1120Q K1121R, D1218R and R1225D.

Characterization of vWFA2 laminin‐332 interaction was also carried out with a vWFA2 lacking any tag residues (untagged vWFA2). This protein construct was isolated from cell lysate by a different strategy as described previously [3](#feb412807-bib-0003){ref-type="ref"}: after an ammonium sulphate precipitation, a cation exchange chromatography was performed followed by a size exclusion chromatography.

CD spectroscopy {#feb412807-sec-0004}
---------------

CD spectra were recorded at 25 °C and 37 °C on a Jasco J‐715 CD photometer (Jasco Corporation, Tokyo, Japan). After subtraction of the blank, molar ellipticities were calculated. For investigating thermal stability of vWFA2, the ellipticity at 220 nm was followed between 25 °C and 90 °C for wild‐type vWFA2 and 5--90 °C for vWFA2 D1218R with a heating rate of 1 K·min^−1^. Protein concentrations were about 10--30 µ[m]{.smallcaps} in 10 m[m]{.smallcaps} sodium phosphate buffer pH 7.4. Melting curves were smoothed by using the Savitzky‐Golay algorithm of the photometer\'s software.

Crystallization and structure solution of vWFA2 {#feb412807-sec-0005}
-----------------------------------------------

The vWFA2 subdomain was crystallized at 10 mg·mL^−1^ in 10 m[m]{.smallcaps} sodium phosphate buffer pH 7.4 with sitting drop vapour diffusion method in 1.8 [m]{.smallcaps} magnesium sulphate, 0.1 [m]{.smallcaps} sodium acetate pH 4.6. The crystals were cryoprotected by adding 20% (v/v) glycerol (final) to the crystallization solution. Diffraction of a small crystal (20 × 80 µm) was collected at the ID29 at the ESRF, France [21](#feb412807-bib-0021){ref-type="ref"}. Data were integrated using the program [xds]{.smallcaps} [22](#feb412807-bib-0022){ref-type="ref"} and further processed using [pointless]{.smallcaps}/[aimless]{.smallcaps}/[ctruncate]{.smallcaps} [23](#feb412807-bib-0023){ref-type="ref"}, [24](#feb412807-bib-0024){ref-type="ref"}, [25](#feb412807-bib-0025){ref-type="ref"}. The phases were solved by molecular replacement with edited PDB entry <http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IGI> [26](#feb412807-bib-0026){ref-type="ref"} as a search model using [phaser]{.smallcaps} [27](#feb412807-bib-0027){ref-type="ref"}. The initial structure was rebuilt with [arp]{.smallcaps}/[warp]{.smallcaps} [28](#feb412807-bib-0028){ref-type="ref"}, [29](#feb412807-bib-0029){ref-type="ref"} and further refined using iterative cycles of [coot]{.smallcaps} [30](#feb412807-bib-0030){ref-type="ref"} and [phenix.refine]{.smallcaps} [31](#feb412807-bib-0031){ref-type="ref"}. Secondary structures were assigned using [dssp]{.smallcaps} [32](#feb412807-bib-0032){ref-type="ref"}, [33](#feb412807-bib-0033){ref-type="ref"}. Figures were generated with [pymol]{.smallcaps} (v.1.7 Schrödinger, LLC, New York, NY, USA). Coordinates of vWFA2 have been deposited in the PDB database under the accession number <http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6S4C>.

Determination of backbone dynamics and residue dipolar coupling measurements {#feb412807-sec-0006}
----------------------------------------------------------------------------

NMR experiments were performed on a Bruker Avance 500 NMR spectrometer (Bruker, Rheinstetten, Germany) at 298 K (25 °C). The spectrometer was equipped with a CPTCI probe head. NMR samples of vWFA2 contained 10 m[m]{.smallcaps} sodium phosphate buffer pH 7.4, 10% (v/v) D~2~O and TSP‐*d* ~4~ as internal standard for referencing. The processing of the spectra was done with Topspin 3.1 (Bruker).

Dynamical behaviour of the protein backbone of vWFA2 was investigated by measuring heteronuclear NOEs, *R* ~1~ (longitudinal) and *R* ~2~ (transversal) relaxation rates. This provides information on the pico‐ to nanosecond timescale [34](#feb412807-bib-0034){ref-type="ref"}. Determination of ^1^H‐^15^N heteronuclear NOEs, *R* ~1~ and *R* ~2~ relaxation rates was done using standard pulse sequences from Bruker. The recovery delay for measurement of *R* ~1~ was set to: 10 ms, 50 ms, 70 ms, 0.1 s, 0.2 s, 0.3s, 0.5s, 0.7 s, 1 s, 1.5 s, 3 s and 5 s. For determination of ^15^N‐*T* ~2~ relaxation times, the following delay times have been used: 17.0, 33.9, 67.8, 84.8, 101.8, 118.7, 135.7, 152.6, 169.6, 203.5 and 237.4 ms. For measuring ^1^H‐^15^N heteronuclear NOEs, a proton saturation time of 3.7 s was used. Evaluation of the data was done with [ccpn]{.smallcaps} [35](#feb412807-bib-0035){ref-type="ref"} by using the published backbone assignment of vWFA2 (BMRB accession number: 17549) [20](#feb412807-bib-0020){ref-type="ref"}.

NH‐residual dipolar couplings were measured using the following alignment media: PEG--hexanol \[final concentration 4.2% (w/v) PEG\] and PEG--hexanol with the positive charged detergent CTAB (1 : 30 CTAB : PEG--hexanol) [36](#feb412807-bib-0036){ref-type="ref"}. The pH of the alignment media was adjusted to 7.3--7.4. Alignment was confirmed by measuring the splitting of the deuterium signal of HDO. Coupling constants have been determined with the IPAP‐HSQC experiment [37](#feb412807-bib-0037){ref-type="ref"} using the Bruker pulse sequence (*hsqcf3gpiaphsiwg*). Assignment of the resonances in the IPAP‐HSQC spectra was done with CCPN [35](#feb412807-bib-0035){ref-type="ref"} based on the published backbone assignment of vWFA2 (BMRB accession number: 17549) [20](#feb412807-bib-0020){ref-type="ref"}. Determination of the alignment tensor and correlation of experimentally determined residue dipolar couplings (RDCs) with back‐calculated RDC values derived from the crystal structure of vWFA2 was done with [pales]{.smallcaps} [38](#feb412807-bib-0038){ref-type="ref"}, [39](#feb412807-bib-0039){ref-type="ref"} using singular value decomposition. RDC and dynamical data have been submitted to the BMRB under the entry 50020 (<http://www.bmrb.wisc.edu/data_library/summary/index.php?bmrbId=50020>).

Cell adhesion assays {#feb412807-sec-0007}
--------------------

Due to the high conservation of the amino acids in human and murine vWFA2 surrounding the RGD motif, we felt safe using murine vWFA2 in combination with human cell lines. Attachment of human cells to vWFA2‐coated surfaces has been performed using the keratinocyte‐like HaCaT cell line [40](#feb412807-bib-0040){ref-type="ref"} (DKFZ Heidelberg) and unmodified human skin fibroblasts (Coriell Institute for Medical Research, GM21808). The proliferating fibroblasts were at a cumulative population doubling level between 20 and 30. A growth curve of this cell line can be found in Ref. [41](#feb412807-bib-0041){ref-type="ref"}. HaCaT cells were grown in CnT‐07 medium (CellNTEC) and the fibroblasts in a 1 : 1 mixture of Ham's F12 Medium/DMEM supplemented with 2 m[m]{.smallcaps} [l]{.smallcaps}‐glutamine and 15% fetal bovine serum (not heat inactivated) (Gibco, Life Technologies Corporation, Grand Island, NY, USA). The cell adhesion assay has been performed as described in Ref. [42](#feb412807-bib-0042){ref-type="ref"}. In brief, after coating 96‐well cell culture plates (Sarstedt AG & Co. KG, Nürnbrecht, Germany) with protein (three wells per concentration), blocking with BSA and washing with PBS 3--5 × 10^5^ cells have been added in DMEM medium (without FBS). After incubation (37 °C, atmosphere with 5 v/v % CO~2~), nonattached cells were removed by washing with PBS. Adherent cells were fixated with a solution of glutaraldehyde, stained with acridine orange and washed. After lysis, absorption was measured at 490 nm and the mean value and error was calculated. In each cell adhesion assay, fibronectin was included as positive control. When investigating mutations, divalent metal ions or antibodies, also a dilution series of wild‐type vWFA2 was included. Cell adhesion assays have been performed at least in triplicate. The effect of divalent metal ions was investigated in the presence of 2 m[m]{.smallcaps} EDTA, 5 m[m]{.smallcaps} MgSO~4~ and 5 m[m]{.smallcaps} MnSO~4~, respectively. The impact of antibodies on cell adhesion was investigated at 5 µg·mL^−1^ for polyclonal anti‐laminin‐332 antibody (Abcam plc, Cambridge, UK), anti‐β1 integrin (P5D2 abcam, AIIB2 Merck Millipore, Merck KGaA, Darmstadt, Germany) and anti‐αV antibody (272‐17E6; abcam) at least in duplicate measurements.

SPR measurements {#feb412807-sec-0008}
----------------

The determination of binding affinities has been done with a BIAcore 3000 (Biacore, Uppsala, Sweden) at 25 °C. Recombinant human laminin‐332 (BioLamina AB, Stockholm, Sweden) was immobilized on a CM5 chip (GE Healthcare Bio‐Sciences AB, Uppsala, Sweden) according to the manufacturer's protocol to yield a final change of approx. 5000 resonance units (RU) relating to maximal 150 RU assuming a monovalent interaction of vWFA2 and laminin‐332. Running buffer was 10 m[m]{.smallcaps} sodium phosphate pH 7.4 150 m[m]{.smallcaps} NaCl. For the investigation of the effect of divalent metal ion, MgCl~2~ was added to a final concentration of 2.5 m[m]{.smallcaps} to the buffer. About 11 and 14 concentrations (ranging between 2.5 and 420 µ[m]{.smallcaps}), respectively, of vWFA2 protein were used for the determination of binding isotherms. Data analysis was done with BIAevaluation 4.1 (Biacore).

Results {#feb412807-sec-0009}
=======

As major component of anchoring fibrils, type VII collagen is essential for skin stability by establishing interactions with proteins of the extracellular matrix. The skin blistering autoimmune disease EBA is a model system for investigating triggers leading to the breakdown of immunotolerance against type VII collagen. Although much information on clinical and immunological data is available for autoimmunity against type VII collagen, high‐resolution structural data and information on interactions with other proteins that would improve our understanding of EBA pathogenesis are still missing. Here, we present the first structural and dynamical data at an atomic level for type VII collagen, which finally lead to the identification of two binding sites at vWFA2 domain. These interactions have not been reported so far for the vWFA2 domain.

Crystallization and measurement of RDC of murine vWFA2 {#feb412807-sec-0010}
------------------------------------------------------

We have determined the crystal structure of the vWFA2 subdomain of murine type VII collagen at a resolution of 2.0 Å (Fig. [2](#feb412807-fig-0002){ref-type="fig"}A--C). The model was refined to satisfactory statistical values of *R* ~work~/*R* ~free~ of 0.18/ 0.21 (Table [1](#feb412807-tbl-0001){ref-type="table"}). The asymmetric unit contained one molecule spanning from G1052 to A1238. The first nine residues of the vWFA2 construct used in this study, that is five residues belonging to the multiple cloning site and the four N‐terminal residues of vWFA2, are not defined in the crystal structure. Interestingly, this includes the N‐terminal cysteine; consequently, the existing disulphide bridge [20](#feb412807-bib-0020){ref-type="ref"} (see also Fig. [S1](#feb412807-sup-0001){ref-type="supplementary-material"}) is not visible in the electron density map. The overall structure is well defined, with an exception of a small loop stretching from R1203 to I1211. Here, density could be seen, but no satisfactory fit could be achieved (Fig. [2](#feb412807-fig-0002){ref-type="fig"}B). Curiously, the crystal contacts are often formed indirectly and not via protein--protein interactions. One crystal contact is formed by a metal‐complexed EDTA molecule. The metal is located on a twofold axis, and the carboxyl groups of EDTA form salt bridges to R1120 of two symmetry mates. Another crystal contact is formed by an inorganic ion (either sulphate or phosphate) sitting on a threefold axis and connecting R1123 of three symmetry‐related molecules. Interestingly, two side‐chain conformations can be observed for K1121. This residue has been shown previously to be crucial for binding type I collagen [11](#feb412807-bib-0011){ref-type="ref"}.

![Crystal structure of vWFA2 of type VII collagen. (A) Cartoon diagram of the vWFA2 subdomain of type VII collagen. β strands and α helices of the vWFA fold are labelled β1--β6 and α1--α6. α5 is not detected as an α‐helix by DSSP and is shown as a green ribbon. α1 starts with a short helical turn and a 3~10~ helix indicated in red. Amino acid residues P1206 and G1207 are not visible and are indicated by a dashed line. (B) Electron density around the undefined amino acids P1206 and G1207 contoured at 1σ. (C) Comparison of different loop structures and their adjacent α5 helix (vWF‐A2 domain (light blue; <http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZQK>), the I domain of integrin α2 (purple; <http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BJ3>) and the type VI collagen α3 N5 domain (dark blue; <http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IGI>). (D) 145 RDCs measured from a PEG--hexanol:CTAB aligned sample correlate well with the theoretical values back‐calculated from the crystal structure (*R* ^2^ = 0.938; *Q* = 0.347, RMSD = 3.11 Hz). Rhombicities (R) of the alignment tensor and the magnitudes (Da) of the alignment tensors are given as inserts. Orange and red values deviate more than 2\*RMSD and 3\*RMSD from the back‐calculated values, respectively. The following residues are labelled in orange: G1185, L1087 and E1199; and in red: L1204 and N1133. (E) Analysis of thermal stability with CD spectroscopy shows that thermal unfolding of wild‐type vWFA2 starts at 55 °C. The sigmoid melting curve has an inflection point of about 64 °C for wild‐type vWFA2 and 50 °C for the vWFA2 D1218R mutant. (F) Determination of heteronuclear ^1^H‐^15^N NOEs points towards increased flexibility for N1133 and residues around T1208. Residues marked in orange are overlapping in the spectra, which can lead to unreasonable or unreliable values.](FEB4-10-580-g002){#feb412807-fig-0002}

###### 

Data collection and refinement statistics for the type VII collagen subdomain vWFA2

                                  vWFA2 domain of Col7
  ------------------------------- ----------------------------------------------------------------
  Data collection                 
  Beamline                        ID29/ESRF
  Wavelength (Å)                  0.9763
  Space group                     R32:h (No. 155)
  Cell dimensions                 
  *a*, *b*, *c* (Å)               123.0, 123.0, 63.7
  α, β, γ (°)                     90.0, 90.0, 120.0
  Resolution (Å)                  35.5--2.0 (2.05--2.00)[a](#feb412807-note-0002){ref-type="fn"}
  *R* ~Sym~                       0.139 (0.709)
  *R* ~meas~                      0.157 (0.802)
  CC~1/2~                         0.995 (0.477)
  *I*/σ*I*                        6.9 (2.1)
  Completeness (%)                99.8 (99.9)
  Multiplicity                    4.4 (4.6)
  Refinement                      
  Resolution (Å)                  35.5--2.0
  No. of reflections (test set)   12573 (626)
  *R* ~work~/*R* ~free~ (%)       17.6/20.6
  No. atoms                       1572
  Protein                         1415
  Ligand/ion                      17
  Water                           140
  B‐factors                       26.8
  Protein                         26.2
  Ligand/ion                      28.2
  Water                           32.7
  R.M.S deviations                
  Bond lengths (Å)                0.003
  Bond angles (°)                 0.76

Highest resolution shell is shown in parentheses.

John Wiley & Sons, Ltd

The α5 helix is not recognized as an α‐helix by DSSP although it has α‐helical character (Fig. [2](#feb412807-fig-0002){ref-type="fig"}A, green 'loop' region). The α‐helical conformation for amino acids in this region is supported by NMR chemical shift data that have been determined in an earlier study [20](#feb412807-bib-0020){ref-type="ref"}. The α1 helix is directly preceded by a helical turn and a short 3~10~ helix formed by residues 18--22 (Fig. [2](#feb412807-fig-0002){ref-type="fig"}A, red helix).

Residue dipolar coupling measurements have been performed to relate the crystal structure with the situation in solution. Alignment of vWFA2 in different alignment media varies as seen by different values measured in a CTAB:PEG--hexanol aligned sample and a PEG--hexanol aligned sample. The measured RDCs are in accordance with the crystal structure. RDCs of backbone amides (NH‐RDC) measured in solution fit well to the crystal structure with sufficient high *R* ^2^ values (Fig. [2](#feb412807-fig-0002){ref-type="fig"}D, Fig. [S3](#feb412807-sup-0001){ref-type="supplementary-material"}). The *R* ^2^ of the PEG--hexanol aligned sample is 0.919 (RMSD 1.96 Hz, 139 RDC values used), and for the CTAB:PEG--hexanol aligned sample *R* ^2^ is 0.938 (RMSD: 3.11 Hz, 145 RDC values used) with quality factors (*Q*‐factor [43](#feb412807-bib-0043){ref-type="ref"}) of 0.347 (CTAB:PEG--hexanol aligned sample) and 0.392 (PEG--hexanol aligned sample). Residues that show the largest deviation of the back‐calculated RDCs from the measured RDCs are D1114, S1131, V1166, E1199, L1204, A1205 and A1233 for the PEG--hexanol aligned sample and L1087, N1133, G1185, E1199 and L1204 for the CTAB:PEG--hexanol aligned sample. In case of the latter alignment medium, all these residues are within loops, whereas for the PEG--hexanol alignment medium all residues except V1166 and A1233 are within loops. Excluding these residues from the analysis improves the fits substantially, indicating a different conformation in the loop structures (as well as reflecting flexibility) in solution state than in the crystal state for these residues. In case of PEG--hexanol, *R* ^2^ increases to 0.958 (132 values used, *Q* = 0.288, RMSD = 1.46 Hz), and for the CTAB:PEG--hexanol aligned sample, *R* ^2^ increases to 0.957 (140 values used, *Q* = 0.290, RMSD = 2.63 Hz) with satisfactory *Q*‐factors [44](#feb412807-bib-0044){ref-type="ref"}, [45](#feb412807-bib-0045){ref-type="ref"}, [46](#feb412807-bib-0046){ref-type="ref"}. As measured RDCs of amino acids within secondary structure elements are in very good accordance with the crystal structure, we conclude that the crystal structure represents the situation in solution at ambient temperature as well.

Dynamic behaviour of murine vWFA2 {#feb412807-sec-0011}
---------------------------------

Dynamic properties of the protein backbone can be investigated by measuring *R* ~1~ and *R* ~2~ relaxation rates. Also, heteronuclear NOEs are very sensitive to backbone flexibility. Analysis of the *R* ~1~ and *R* ~2~ relaxation rates as well as heteronuclear NOEs shows two regions within vWFA2 that are characterized by increased flexibility as compared to the bulk residues (Fig. [2](#feb412807-fig-0002){ref-type="fig"}F, Fig. [S4](#feb412807-sup-0001){ref-type="supplementary-material"}). Besides the terminal residues, N1133, N1219 and residues around A1205 show reduced *R* ~2~ relaxation rates. Heteronuclear NOEs are markedly decreased for residues N1133 and T1208. This is indicating local flexibility at the nanoseconds to picoseconds time scale and can be explained by the localization of these residues within loops. This is in line with the crystallographic data where the loop bridging helix α5 with β‐strand β6 is not well defined.

Thermal stability of vWFA2 {#feb412807-sec-0012}
--------------------------

CD spectra of vWFA2 at 25 °C and 37 °C are virtually identical with a minimum at 220 nm (Fig. [S5](#feb412807-sup-0001){ref-type="supplementary-material"}). Analysis of the percentage of secondary structure elements using the K2D3 web service [47](#feb412807-bib-0047){ref-type="ref"} resulted in 34% α‐helical and 19% β‐sheet‐like structures, respectively. These values are in very good agreement with the content of α‐helix (36%) and β‐sheet (19%) determined from the crystal structure. The melting temperature of vWFA2 is about 64 °C (Fig. [2](#feb412807-fig-0002){ref-type="fig"}E), and thus, vWFA2 is stable also at temperatures considerably above body temperature; that is, at temperatures used for the cell adhesion experiments, vWFA2 is stable and adopts the structure determined by crystallography. Of the mutants generated for identifying the binding sites for cellular receptors (*vide infra*), the vWFA2 R1120Q K1121R D1218R mutant could not be investigated due to low yield after purification. Analysing thermal stability of vWFA2 D1218R shows that this mutant is less stable with a melting temperature of about 50 °C. This demonstrates that D1218 is stabilizing the vWFA2 subdomain and thereby preventing mutations at this site.

Cell adhesion assays show binding of vWFA2 to integrins and laminin‐332 {#feb412807-sec-0013}
-----------------------------------------------------------------------

vWFA2 contains a potential RGD motif, which is an interaction site for integrins. It was previously shown that the NC1 domain of type VII collagen is interacting with α2β1 integrin [48](#feb412807-bib-0048){ref-type="ref"}. The interaction site was located at N‐terminal subdomains by analysing shortened NC1‐fragments; thus, it was concluded that the interaction is RGD independent [48](#feb412807-bib-0048){ref-type="ref"}. As seen in the crystal structure, the RGD motif is at the protein surface and the RGD motif is also conserved between different species (see Fig. [S7](#feb412807-sup-0001){ref-type="supplementary-material"}). Thus, it was tested whether vWFA2 can interact with surface proteins of dermal cells. Both keratinocyte‐like HaCaT cells and unmodified human fibroblasts show binding to vWFA2 in a cell attachment assay (Fig. [3](#feb412807-fig-0003){ref-type="fig"}A). Mutating the RGD motif to DGR (R1171D D1173R) seemed not to influence cell binding (Fig. [3](#feb412807-fig-0003){ref-type="fig"}B, Fig. [S6](#feb412807-sup-0001){ref-type="supplementary-material"}). Since vWFA2 has been shown to be involved in type I collagen, which is produced by fibroblasts, that binding site was also mutated (R1120Q K1121R) to preclude this interaction [11](#feb412807-bib-0011){ref-type="ref"}. Since cell attachment seemed not to be affected (Fig. [3](#feb412807-fig-0003){ref-type="fig"}B), this led to the assumption that a further interaction site exists. To substantiate this hypothesis, a third mutation was introduced at different positions. Based on the crystal structure, amino acids located on the protein's surface have been changed. The vWFA2 R1120Q K1121R D1218R mutant could not be tested in the cell attachment assay due to low yield after purification. Therefore, residues nearby this position have been mutated. Of these mutations tested in the cell attachment assay only the mutant containing the following mutations R1225D, mutation of the RGD motif (R1171D, D1173R) and the type I collagen binding site (R1120Q, K1121R) showed reduced binding compared to wild‐type vWFA2. The R1225D mutation alone showed no reduced binding in the cell attachment assay, as the RGD motif is intact.

![Identification of binding sites for vWFA2. Representative plots of cell adhesion assays are shown. (A) Human skin fibroblasts and the keratinocyte‐like HaCaT cell line show adhesion to vWFA2‐coated surfaces comparable to fibronectin. Mutation of vWFA2 shows decreased binding in case of the DGR R1120Q K1121R R1225D mutant, thereby pointing towards two interactions sites at vWFA2 (B). Data for fibroblasts are shown in Fig. [S6](#feb412807-sup-0001){ref-type="supplementary-material"}. (C) The presence of EDTA shows virtually no binding for the vWFA2 R1225D mutant and reduced binding for the vWFA2 DGR mutant in cell adhesion assays with HaCaT cells. Thus, binding via the RGD motif is depending on divalent metal ions and binding via the binding site at R1225 is at least influenced by the presence of divalent metal ions. Attachment of HaCaT cells is also reduced in the presence of an anti‐integrin β1 antibody for D1218R mutant and anti‐laminin‐332 antibody for the vWFA2 DGR mutant (D). It seems that the anti‐integrin β1 antibody also affects the interaction with laminin‐332 as the wild‐type vWFA2 show reduced binding in the presence of this antibody. This is likely an indirect effect since laminin‐332 is also interacting with integrins. Error bars for cell adhesion plots represent the standard deviation of a triplicate measurement.](FEB4-10-580-g003){#feb412807-fig-0003}

After establishing the existence of two binding sites on vWFA2 (RGD and R1225) for cell surface receptors, the dependency on divalent metal ions was tested (Fig. [3](#feb412807-fig-0003){ref-type="fig"}C) since integrin binding requires divalent metal ions. Binding was not enhanced when Mg^2+^ or Mn^2+^ was added but reduced for each binding site in the presence of EDTA, indicating that the interaction is dependent on divalent metals.

Initial SPR (surface plasmon resonance) experiments pointed towards an interaction of laminin‐332 with vWFA2; hence, a polyclonal anti‐laminin‐332 antibody was tested and reduced binding in the cell adhesion assay was observed for the DGR mutant (Fig. [3](#feb412807-fig-0003){ref-type="fig"}D). Investigating different antibodies in their ability to block the interaction of RGD motif with integrins reduced binding was observed with anti‐β1 antibodies but not with anti‐αV antibodies (Fig. [3](#feb412807-fig-0003){ref-type="fig"}D, Fig. [S6](#feb412807-sup-0001){ref-type="supplementary-material"}). Also for wild‐type vWFA2, a reduction in cell adhesion was observed in the presence of anti‐β1 antibodies, which is likely an indirect effect since laminin‐332 can also interact with α3β1‐integrin [49](#feb412807-bib-0049){ref-type="ref"}.

Quantification of the laminin‐332 vWFA2 interaction by SPR measurements {#feb412807-sec-0014}
-----------------------------------------------------------------------

In order to quantitate the interaction of vWFA2 with laminin‐332, SPR was used (Fig. [4](#feb412807-fig-0004){ref-type="fig"}A). Preliminary SPR experiments indicated that the interaction is very weak, and according to literature, the laminin‐332 binding site is located at subdomains FNIII7‐9 of type VII collagen [8](#feb412807-bib-0008){ref-type="ref"}, [50](#feb412807-bib-0050){ref-type="ref"}. In order to make certain that the observed interaction is not artificial, the *K* ~D~ was determined in two independent experiments. Therefore, two different laminin‐332 charges and two different vWFA2 constructs were used: vWFA2 (purified by intein cleavage) showed a *K* ~D~ of 0.81 m[m]{.smallcaps} (*Χ* ^2^ = 8.48, Fig. [4](#feb412807-fig-0004){ref-type="fig"}A) and untagged‐vWFA2 purified by cation exchange chromatography and size exclusion chromatography showed a *K* ~D~ of 0.44 m[m]{.smallcaps} (*Χ* ^2^ = 0.25). Since it is a low‐affinity interaction and, in the cell attachment assays, residual binding of cells to mutant proteins was still observed, SPR cannot be employed for reliable quantification of the impact of mutations on this interaction. The binding seems not to be dependent on divalent metal ions, since the *K* ~D~ of this interaction is 1.1 m[m]{.smallcaps} in the presence of Mg^2+^ (*Χ* ^2^ = 5.5).

![Quantitation of the laminin‐332 interaction. (A) The interaction of vWFA2 and laminin‐332 is confirmed and quantified by SPR analysis yielding a *K* ~D~ value of 0.81 m[m]{.smallcaps} (*Χ* ^2^ = 8.48). (B) Residues within 10 Å of the N‐/C‐terminus, the RGD motif and the type I collagen binding site are differently coloured to estimate the potential steric demands of these interactions (note that the colour coding is not related to the colours in Fig. [3](#feb412807-fig-0003){ref-type="fig"}A--D). This shows that the direct surrounding of R1225 is not involved in any of these interactions, which could reflect the hitherto unknown interaction site.](FEB4-10-580-g004){#feb412807-fig-0004}

Discussion {#feb412807-sec-0015}
==========

Autoantibodies against the vWFA2 subdomain of type VII collagen are pathologically relevant in the autoimmune skin blistering disease EBA. This is demonstrated in a mouse model for experimental EBA based on immunization with vWFA2 [19](#feb412807-bib-0019){ref-type="ref"}. In addition, autoantibodies against vWFA2 are also detected in patients. To improve the understanding of structural consequences caused by autoantibody binding, we structurally characterized the vWA2 domain. Based on the high‐resolution structural data, mutations were introduced leading to the identification of two hitherto unknown binding sites at the vWFA2 domain: laminin‐332 and a β1 integrin.

Structure of the murine type VII collagen subdomain vWFA2 {#feb412807-sec-0016}
---------------------------------------------------------

The structure resembles a typical von Willebrand factor A domain (vWA) fold consisting of a central β‐sheet (β1--β6) surrounded by α‐helices (α1--α4, α6) (Fig. [2](#feb412807-fig-0002){ref-type="fig"}A). RDC measurements with NMR spectroscopy prove that at ambient temperature this structure also exists in solution. A search for similar structures using the DALI server [51](#feb412807-bib-0051){ref-type="ref"} identified the vWA domains of type VI collagen [26](#feb412807-bib-0026){ref-type="ref"}, αII integrin [52](#feb412807-bib-0052){ref-type="ref"}, the von Willebrand factor A2 domain [53](#feb412807-bib-0053){ref-type="ref"} and PTMP‐1 [54](#feb412807-bib-0054){ref-type="ref"} as being the most similar structures. In comparison with those structures, our newly solved structure shows a more rigid and straightened α6 helix (Fig. [S2](#feb412807-sup-0001){ref-type="supplementary-material"}). In the crystal structure, it is also seen the side chain of D1218 points towards the N terminus of helix α6 --- likely stabilizing the helix. This hypothesis is supported by the fact that the D1218R mutants could only be isolated in low yields and the thermal stability of the D1218R mutant is lower compared to wild‐type vWFA2 (Fig. [2](#feb412807-fig-0002){ref-type="fig"}E). The loop connecting the α5 helix and the β6 sheet is not well defined in the structure, indicating a higher degree of flexibility (Fig. [2](#feb412807-fig-0002){ref-type="fig"}B). This is in very good agreement with NMR data pointing towards increased backbone flexibility at the nanoseconds to picoseconds time scale in this region (Fig. [2](#feb412807-fig-0002){ref-type="fig"}F, Fig. [S4](#feb412807-sup-0001){ref-type="supplementary-material"}). However, the defined parts of this loop differ significantly from loop structures of other vWA domains (Fig. [2](#feb412807-fig-0002){ref-type="fig"}C).

The crystal structure shows electrostatic interactions with EDTA and inorganic anions at the type I collagen binding site. As we have previously shown that the interaction of vWFA2 with type I collagen relies on electrostatic interactions [11](#feb412807-bib-0011){ref-type="ref"}, it is curious to observe contacts with negative charges in the crystal structure at this position.

Interactions of the murine type VII collagen subdomain vWFA2 {#feb412807-sec-0017}
------------------------------------------------------------

vWFA2 domain has been described as binding site for type I collagen [10](#feb412807-bib-0010){ref-type="ref"}, [11](#feb412807-bib-0011){ref-type="ref"}. The domain also harbours an RGD motif for which literature claims that it is not involved in integrin binding [48](#feb412807-bib-0048){ref-type="ref"}. However, cell adhesion assays with the keratinocyte‐like HaCaT cell line and human normal fibroblasts proved that vWFA2 is binding to cells. Mutation analysis showed that there are two binding sites that allow attachment of cells (Fig. [4](#feb412807-fig-0004){ref-type="fig"}B). One binding event is mediated via the RGD motif and is depending on divalent metal ions. Information about the cellular receptor that is involved in this binding was obtained by using different anti‐integrin antibodies -- only antibodies against the β1 chain show reduced cell attachment. The second binding site is located at R1225 (see also Fig. [S6](#feb412807-sup-0001){ref-type="supplementary-material"}), and the interaction is inhibited in the presence of anti‐laminin‐332 antibodies. The interaction with laminin‐332 is surprising as earlier reports located this binding site to the FNIII‐like domains 7--9 [8](#feb412807-bib-0008){ref-type="ref"}, [50](#feb412807-bib-0050){ref-type="ref"}. SPR analysis showed that the interaction is of low affinity with a *K* ~D~ of about 0.8 m[m]{.smallcaps}. Assuming another laminin‐332 binding site in full‐length type VII collagen as described in the literature, this will result in a more affine binding due to multivalency effects. That can explain the difference in affinity of monomeric vWFA2 domain compared to mini‐type VII collagen, which was determined to be 60 n[m]{.smallcaps} by Brittingham *et al*. [7](#feb412807-bib-0007){ref-type="ref"}. It should also be kept in mind that the vWFA2 domain contains a potential glycosylation, which is missing in the investigated construct due to the expression in *Escherichia coli.* Finally, in this study the interaction of murine vWFA2 and recombinant human laminin‐332 was investigated, whereas the reported values have been determined with purified rat laminin‐332 and human type VII collagen constructs [7](#feb412807-bib-0007){ref-type="ref"}. Since native type VII collagen is a homotrimer, that is it contains three vWFA2 domains, thereby increasing the local concentration in the dermal--epidermal junction rendering this interaction more relevant *in vivo*. Due to the high *K* ~D~ value, it is not possible to determine the impact of mutations investigated in the cell attachment assay as these mutations showed still binding in the assays. Since laminin‐332 -- a component of the basement membrane can bind cellular surface proteins too, the diminished binding in the presence of EDTA can also be an indirect effect, which is supported by SPR showing no enhanced binding of vWFA2 to laminin‐332 in the presence of Mg^2+^.

It is somehow curious that vWFA2 has additional interaction partners besides the well‐established binding to type I collagen [10](#feb412807-bib-0010){ref-type="ref"}, [11](#feb412807-bib-0011){ref-type="ref"}. It is tentative to speculate that depending on the location of type VII collagen it can exert different functions: when deposited at the dermal--epidermal junction, it mediates stability by binding to type I collagen, but in case of binding to other (cellular) targets, it could activate different signalling pathways, which might be related to wound healing [55](#feb412807-bib-0055){ref-type="ref"}.

Future studies should focus on the identification of the integrin ligand. Knowing the integrin partner will allow a more detailed analysis of the accessibility of the vWFA2 binding sites in the skin and exploration of the signalling pathways related to the vWA2 subdomain.

Concluding remarks {#feb412807-sec-0018}
==================

The cause for loss of tolerance against type VII collagen in the development of EBA is unclear. It was currently shown that autoimmunity against vWFA2 causes skin blistering in experimental EBA. These data are now complemented with the first high‐resolution biophysical characterization of the vWFA2 subdomain of type VII collagen. In combination with functional studies, that is identification of two binding sites that have not been so far attributed to the vWFA2 domain, this provides new detailed insights into the function of type VII collagen. It lays the basis for investigating the putative glycosylation site of vWFA2 for a better understanding of type VII collagen function in the extracellular matrix.
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**Fig. S1.** In a coomassie stained 15% SDS‐PAGE analysis of murine vWFA2, it shows a different migration behaviour under reducing and non‐reducing conditions, respectively; indicating that a disulphide bridge formed by the two cysteines is present (a). In addition, under non‐reducing conditions also a band at a molecular weight corresponding to a dimer is present. (b) Amino acid sequence of the investigated construct. Residues underlined and in italic font at the N‐terminus belong to the intein tag. The two cysteines forming the disulphide bridge are labelled in orange (residues 1049 and 1235). N1110 is potentially glycosylated.

**Fig. S2.** Overlay of the Col7 vWFA2 domain (orange) with the vWF‐A2 domain (light blue; 3ZQK; RMS: 2.75 Å), the type VI collagen α3 N5 domain (dark blue; 4IGI, RMS: 1.29 Å), the PTMP1‐A1 domain (green, 4CNB_A; RMS: 1.17 Å) and the I domain of integrin α2 (purple; 4BJ3; RMS: 1.66 Å).

**Fig. S3.** (a) 139 RDCs measured from a PEG‐hexanol aligned sample correlate well with the theoretical values back‐calculated from the crystal structure (*R* ^2^ = 0.919, *Q* = 0.392, RMSD = 1.96 Hz). Orange and red values deviate more than 2\*RMSD and 3\*RMSD from the back‐calculated values, respectively and are plotted on the crystal structure of vWFA2 (b). (c) Secondary structure elements of vWFA2. (d, e) Deviation of measured NH‐RDCs for the individual amino acids (black symbols) compared to the back‐calculated values (gray symbols) according to the crystal structure.

**Fig. S4.** NMR relaxation data of the vWFA2 domain determined by NMR spectroscopy. (a) secondary structure elements of vWFA2. Determination of relaxation rates *R* ~1~ (b), *R* ~2~ (c), *R* ~2~/*R* ~1~ (d) and heteronuclear ^1^H‐^15^N NOEs (e) points towards increased flexibility for N1133 and residues around T1208. Residues marked in orange are overlapping in the spectra which can lead to unreasonable values (e.g. as seen for ^1^H‐^15^N NOEs).

**Fig. S5.** CD spectroscopy of vWFA2. CD spectroscopy shows that the overall fold at 25°C and 37°C is identical and the percentages of secondary structure elements are in very good agreement with the crystal structure with 34 % α‐helix and 19 % β‐sheet structures.

**Fig. S6.** Cell adhesion of fibroblasts to vWFA2. The effect of cell adhesion of fibroblasts was investigated by using different vWFA2 mutants. Mutations that show in combination a diminished binding of vWFA2 to fibroblasts due to interference with protein‐protein‐interactions are shown in (a). Mutations, that have also been tested in cell adhesion assay but which do not interfere in binding of vWFA2 since they are distant to the interaction site are shown in (b). (c) Residues within 10 Å of the N‐/C‐terminus, the RGD motif and the type I collagen binding site are differently coloured to estimate the potential steric demands of these interactions. This shows that the direct surrounding of R1225 is not involved in any of these interactions which could reflect the hitherto unknown interaction site. (d) An antibody against β1‐integrin (P5D2) shows a reduction of binding whereas an αV integrin (272‐17E6) antibody does not interfere with cell binding in the cell adhesion assay. Error bars for cell adhesion plots represent the standard deviation of a triplicate measurement.

**Fig. S7.** Differences in surface accessible amino acids near the RGD motif of vWFA2. Surface representation of murine vWFA2 with the amino acids of the RGD motif labelled in red. Residues labelled in gray are identical between human and murine vWFA2 domain whereas amino acids labelled in yellow are different showing that the surrounding of the RGD motif is quite conserved between the two species. Sequence identity between the two molecules is 80%.
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Data availability statement {#feb412807-sec-0023}
===========================

Coordinates and structure factors of vWFA2 have been deposited in the PDB database (accession number <http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6S4C>). RDC and dynamical data have been deposited at the BMRB (entry‐ID 50020, <http://www.bmrb.wisc.edu/data_library/summary/index.php?bmrbId=50020>).
